BACKGROUND: Smoking cessation for individuals with depressive disorders represents an important clinical issue. It often has been hypothesized that smoking cessation worsens negative affect as part of the withdrawal process in this population. However, studies examining the impact of smoking cessation on changes in affect in smokers with depression are limited and equivocal. METHODS: This study examines affective processes in smokers with depression undergoing a 12-week smoking cessation intervention (N = 49). We used the Positive and Negative Affect Scale to measure participants' positive affect (PA) and negative affect (NA) trajectories over the course of a quit attempt. We examined whether affective treatment response across the trial differed by prolonged smoking abstinence status and whether postquit affect differed by prequit affective treatment response, as well as the interaction of prequit affective response and abstinence status. RESULTS: Prolonged abstainers showed significant increases in PA over the course of a quit attempt compared with nonabstainers. Prequit affective trajectories significantly predicted postquit affect for measures of both PA and NA. Lastly, the interaction of prequit affective trajectory and abstinence significantly predicted postquit levels of NA but not PA. CONCLUSIONS: This study adds to a burgeoning body of research demonstrating that significant improvements in psychological functioning can be observed among those who successfully quit smoking even in the most severe psychiatric group.
BACKGROUND: Smoking cessation for individuals with depressive disorders represents an important clinical issue. It often has been hypothesized that smoking cessation worsens negative affect as part of the withdrawal process in this population. However, studies examining the impact of smoking cessation on changes in affect in smokers with depression are limited and equivocal. METHODS: This study examines affective processes in smokers with depression undergoing a 12-week smoking cessation intervention (N = 49). We used the Positive and Negative Affect Scale to measure participants' positive affect (PA) and negative affect (NA) trajectories over the course of a quit attempt. We examined whether affective treatment response across the trial differed by prolonged smoking abstinence status and whether postquit affect differed by prequit affective treatment response, as well as the interaction of prequit affective response and abstinence status. RESULTS: Prolonged abstainers showed significant increases in PA over the course of a quit attempt compared with nonabstainers. Prequit affective trajectories significantly predicted postquit affect for measures of both PA and NA. Lastly, the interaction of prequit affective trajectory and abstinence significantly predicted postquit levels of NA but not PA. CONCLUSIONS: This study adds to a burgeoning body of research demonstrating that significant improvements in psychological functioning can be observed among those who successfully quit smoking even in the most severe psychiatric group.
Authors: Adam M Leventhal; Christopher W Kahler; Lara A Ray; Kristen Stone; Diane Young; Iwona Chelminski; Mark Zimmerman Journal: Am J Addict Date: 2008 May-Jun
Authors: Danielle E McCarthy; Thomas M Piasecki; Daniel L Lawrence; Douglas E Jorenby; Saul Shiffman; Timothy B Baker Journal: Addiction Date: 2008-09 Impact factor: 6.526
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: A Eden Evins; Melissa A Culhane; Jonathan E Alpert; Joel Pava; Bruce S Liese; Amy Farabaugh; Maurizio Fava Journal: J Clin Psychopharmacol Date: 2008-12 Impact factor: 3.153
Authors: Mira Bühler; Sabine Vollstädt-Klein; Andrea Kobiella; Henning Budde; Laurence J Reed; Dieter F Braus; Christian Büchel; Michael N Smolka Journal: Biol Psychiatry Date: 2009-12-30 Impact factor: 13.382
Authors: Judith J Prochaska; Sharon M Hall; Janice Y Tsoh; Stuart Eisendrath; Joseph S Rossi; Colleen A Redding; Amy B Rosen; Marc Meisner; Gary L Humfleet; Julie A Gorecki Journal: Am J Public Health Date: 2007-06-28 Impact factor: 9.308
Authors: P A Cavazos-Rehg; N Breslau; D Hatsukami; M J Krauss; E L Spitznagel; R A Grucza; P Salyer; S M Hartz; L J Bierut Journal: Psychol Med Date: 2014-09 Impact factor: 7.723
Authors: David G Gilbert; Norka E Rabinovich; Elizabeth A Gilbert-Matuskowitz; Keith P Klein; Michele L Pergadia Journal: Exp Clin Psychopharmacol Date: 2019-03-28 Impact factor: 3.492
Authors: Lee Hogarth; Zhimin He; Henry W Chase; Andy J Wills; Joseph Troisi; Adam M Leventhal; Amanda R Mathew; Brian Hitsman Journal: Psychopharmacology (Berl) Date: 2015-06-05 Impact factor: 4.530